David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,000 shares at $41.76 ($209K) on 2013-11-08, disclosed to the SEC on 2013-11-13.
Scheduled sale ($209k) by Executive VP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |